Salix Adds to Gastroenterology Franchise with US$2.6 B Santarus Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 11 (Table of Contents)
Published: 22 Nov-2013
DOI: 10.3833/pdr.v2013.i11.1992 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Gastroenterology specialist Salix Pharmaceuticals has agreed to acquire Santarus in an all-cash transaction that values the company at approximately US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS